Header Logo

Connection

Summer Dewdney to Endometrial Neoplasms

This is a "connection" page, showing publications Summer Dewdney has written about Endometrial Neoplasms.
Connection Strength

0.968
  1. Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers. Clin Cancer Res. 2011 Apr 15; 17(8):2120-9.
    View in: PubMed
    Score: 0.382
  2. TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study. J Clin Oncol. 2022 10 01; 40(28):3289-3300.
    View in: PubMed
    Score: 0.208
  3. Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study. Gynecol Oncol. 2021 04; 161(1):113-121.
    View in: PubMed
    Score: 0.190
  4. Society of Gynecologic Oncology Clinical Outcomes Registry: From small beginnings come great things. Gynecol Oncol. 2018 03; 148(3):439-444.
    View in: PubMed
    Score: 0.154
  5. Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome. JAMA. 2016 Jul 05; 316(1):93-4.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.